Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
      • The Challenge Initiative Platform
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • Other Useful Sites
    • GH eLearning
    • GHJournal Search
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Webinars
    • Local Voices Webinar
    • Connecting Creators and Users of Knowledge
    • Publishing About Programs in GHSP
  • Alerts
  • Visit GHSP on Facebook
  • Follow GHSP on Twitter
  • RSS
  • Find GHSP on LinkedIn
LETTER TO THE EDITOR
Open Access

Editors’ Response to Omotayo: Research Needed on Better Prevention of Pre-Eclampsia

Global Health: Science and Practice June 2016, 4(2):352-353; https://doi.org/10.9745/GHSP-D-16-00136
PreviousNext
  • Article
  • Info & Metrics
  • Comments
  • PDF
Loading

See related article by Omotayo.

We appreciate points made by Omotayo and colleagues1 in their comment on our earlier GHSP editorial on pre-eclampsia and perinatal mortality.2 They draw attention to deficiencies in the care of preterm newborns that can limit the impact of other elements of a comprehensive approach to pre-eclampsia. In settings accounting for the greatest burden of mortality attributable to preterm birth, a large proportion of births are in health facilities lacking capabilities for neonatal intensive care. Nevertheless, core elements of good care of preterm and very small newborns can still feasibly be delivered in settings with limited resources.

Kangaroo mother care (KMC) was originally developed in response to limited access to incubators and other elements of neonatal intensive care but was subsequently documented to give better outcomes than conventional high-tech care.3 Consequently, KMC is now being promoted in high-income countries due to its effectiveness, not merely as a low-cost alternative. From this experience, it’s evident that much can be done, even in very resource-constrained settings, to improve key elements of care of preterm and very small newborns, notably:

  • Good thermal care—maximizing skin-to-skin contact

  • Conscientious and capable attention given to feeding—relying on breastmilk only, to the extent appropriate, and providing any needed support, e.g., breastmilk expression and cup feeding or tube feeding

  • Vigilance, through good nursing care, to pick up complications early and respond appropriately

Omotayo et al. further elaborate on a point made in the editorial about expected impact from systematic antenatal screening for pre-eclampsia followed by timely delivery. Goldberg and colleagues4 have argued persuasively that these factors account for the bulk of the decline in pre-eclampsia–related deaths experienced in high-income countries over the past century.

Their third main argument is that more can be done to prevent pre-eclampsia from developing in the first place, pointing specifically to aspirin and calcium supplementation. Certainly for those at particular risk, notably women with a previous history of pre-eclampsia,5 low-dose aspirin is effective. But the proportion of serious outcomes of pre-eclampsia preventable with this intervention is relatively modest. Of greater potential population impact would be widespread uptake of antenatal calcium supplementation.6 Available evidence suggests that in populations with low calcium intake, all-cause newborn mortality could be reduced by as much as 30% with near universal coverage of this intervention.

But the problem is the dose of calcium. The current recommendation from the World Health Organization for antenatal supplementation is 1500–2000 mg (3–4 tablets) of elemental calcium per day. At a weight of 1.25 g/tablet, that translates to a pound and a half of tablets per pregnancy. Furthermore, at this dosing, the cost for antenatal calcium supplementation is close to an order of magnitude greater than for antenatal iron-folate supplementation.

There is reason to believe that a closer-to-physiologic dosing of 500 mg of elemental calcium per day may give similar benefit.7 But available evidence is not yet sufficient to warrant changing the current recommendations. In the meantime, this practical problem of weight, bulk, and cost constitutes an important barrier for provision in the low-resource settings where this intervention could give the greatest benefit.

What is needed is a dose-finding study to determine if a lower dose can reduce risk of serious pre-eclampsia outcomes such as perinatal death to a similar degree to that which has been documented with high-dose supplementation.

It’s time for one our donor partners (e.g., the United States Agency for International Development, the Bill & Melinda Gates Foundation, or the National Institutes of Health) to step up to the plate to fund the needed research to remove this formidable barrier. –Global Health: Science and Practice

The problem: feasibility of delivery of the currently recommended high dose for calcium supplementation.

The solution: a study to determine if low-dose calcium also works.

Notes

Cite this article as: Editors’ response to Omotayo: research needed on better prevention of pre-eclampsia. Glob Health Sci Pract. 2016;4(2):352-353. http://dx.doi.org/10.9745/GHSP-D-16-00136">http://dx.doi.org/10.9745/GHSP-D-16-00136

  • © Global Health: Science and Practice.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: http://dx.doi.org/10.9745/GHSP-D-16-00136.

REFERENCES

  1. ↵
    1. Omotayo M,
    2. Dickin K,
    3. Stolzfus R
    . Perinatal mortality due to pre-eclampsia in Africa: a comprehensive and integrated approach is needed. Glob Health Sci Pract. 2016;4(2):350–351. doi:10.9745/GHSP-D-16-00054
    OpenUrlCrossRef
  2. ↵
    1. Hodgins S
    . Pre-eclampsia as underlying cause for perinatal deaths: time for action. Glob Health Sci Pract. 2015;3(4):525–527. doi:10.9745/GHSP-D-15-00350. pmid:26681699
    OpenUrlFREE Full Text
  3. ↵
    1. Conde-Agudelo A,
    2. Díaz-Rossello JL
    . Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev. 2014;(4):CD002771. doi:10.1002/14651858.CD002771.pub3. pmid:24752403
    OpenUrlCrossRefPubMed
  4. ↵
    1. Goldenberg R,
    2. McClure E,
    3. Macguire ER,
    4. Kamath BD,
    5. Jobe AH
    . Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet. 2011;113(2):91–95. doi:10.1016/j.ijgo.2011.01.002. pmid:21349517
    OpenUrlCrossRefPubMed
  5. ↵
    1. Coomarasamy A,
    2. Honest H,
    3. Papaioannou S,
    4. Gee H,
    5. Khan KS
    . Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol. 2003;101(6):1319–1332. pmid:12798543
    OpenUrlCrossRefPubMed
  6. ↵
    1. Villar J,
    2. Abdel-Aleem H,
    3. Merialdi M,
    4. Mathai M,
    5. Ali MM,
    6. Zavaleta N,
    7. et al.
    World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006;194(3):639–649. doi:10.1016/j.ajog.2006.01.068. pmid:16522392
    OpenUrlCrossRefPubMed
  7. ↵
    1. Hofmeyr GJ,
    2. Belizán JM,
    3. von Dadelszen P
    Calcium and Pre-eclampsia (CAP) Study Group. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. BJOG. 2014;121(8):951–957. doi:10.1111/1471-0528.12613. pmid:24621141
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 4 (2)
Global Health: Science and Practice
Vol. 4, No. 2
June 20, 2016
  • Table of Contents
  • About the Cover
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Editors’ Response to Omotayo: Research Needed on Better Prevention of Pre-Eclampsia
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Editors’ Response to Omotayo: Research Needed on Better Prevention of Pre-Eclampsia
Global Health: Science and Practice Jun 2016, 4 (2) 352-353; DOI: 10.9745/GHSP-D-16-00136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Editors’ Response to Omotayo: Research Needed on Better Prevention of Pre-Eclampsia
Global Health: Science and Practice Jun 2016, 4 (2) 352-353; DOI: 10.9745/GHSP-D-16-00136
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • Notes
    • REFERENCES
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Author’s Response to Letter on “Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria”
  • Regarding “Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria”
  • Regarding “A Cluster-Randomized Trial to Test Sharing Histories as a Training Method for Community Health Workers in Peru”
Show more LETTER TO THE EDITOR

Similar Articles

Subjects

  • Health Topics
    • Maternal, Newborn, and Child Health
US AIDJohns Hopkins Center for Communication ProgramsUniversity of Alberta

Follow Us On

  • Twitter
  • Facebook
  • LinkedIn
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers
  • GH Journals Database

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2023 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire